Overview

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This is an 18-week, prospective, multi-center, randomized, double-blind, placebo-controlled, (1:1) parallel-group study.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Limited
Treatments:
Donepezil